Corcept Therapeutics (HTD) Q1 2026 Earnings Report
DE:HTD Q1 2026 EPS Results
- Actual EPS
- -EUR 0.27
- Consensus EPS
- -EUR 0.10
- Beat/Miss
- Missed by -EUR 0.17
- One Year Ago EPS
- EUR 0.15
DE:HTD Q1 2026 Revenue Results
- Actual Revenue
- EUR 147.44M
- Expected Revenue
- EUR 165.65M
- Beat/Miss
- Missed by -EUR 18.21M
- YoY Revenue Growth
- +4.89%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 04/30/2026
- Time
- After Close
- Conference Call
- Thursday, April 30, 2026
DE:HTD Upcoming Earnings
Corcept Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
DE:HTD Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:HTD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | ―- | 0.18 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | 0.71- | 0.14 | ― | |
| Jul 29, 2026 | 2026 (Q2) | 0.020.32 | 0.26 | 24.14% (+0.06) | |
| Apr 30, 2026 | 2026 (Q1) | -0.10-0.27 | 0.15 | -276.47% (-0.42) | |
| Feb 24, 2026 | 2025 (Q4) | 0.290.18 | 0.23 | -23.08% (-0.05) | |
| Nov 04, 2025 | 2025 (Q3) | 0.150.14 | 0.37 | -60.98% (-0.22) | |
| Jul 31, 2025 | 2025 (Q2) | 0.170.26 | 0.29 | -9.38% (-0.03) | |
| May 05, 2025 | 2025 (Q1) | 0.130.15 | 0.22 | -32.00% (-0.07) | |
| Feb 26, 2025 | 2024 (Q4) | 0.380.23 | 0.25 | -7.14% (-0.02) | |
| Oct 30, 2024 | 2024 (Q3) | 0.250.37 | 0.25 | 46.43% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
